• Creative Peptides Unveils Product Portfolio of Standard Fmoc/Boc-PNA Monomers

    May 27, 2022, 09:15 by
    Creative Peptides supplies standard Fmoc- and Boc-PNA monomers that can be ordered in large quantities with high purity, solubility, and reactivity.
    Full story
  • Complete Virtual Screening Solutions at BOC Sciences to Unleash Novel Drug Discovery Potential

    May 27, 2022, 09:15 by
    Today, BOC Sciences released a complete set of virtual screening solutions to help partners maximize the diversity of hits using its ultra-large-scale purchasable compound libraries.
    Full story
  • BOC Sciences Unveils Access to Comprehensive Set of PROTAC In Vitro Evaluation Services

    May 27, 2022, 09:15 by
    BOC Sciences today unveiled access to its comprehensive set of PROTAC in vitro evaluation services for biopharmaceutical clients and partners to expedite their PROTAC development from preclinical studies to clinical trials.
    Full story
  • CD ComputaBio Introduces IPA Analysis Service to Speed Up Your Research

    May 27, 2022, 09:15 by
    Full story
  • DFE Pharma opens its new Center of Excellence in India to provide fast-track formulation services

    May 27, 2022, 09:15 by
    Full story
  • Unleashing the Value of Study Data with Digital Health Technology

    May 27, 2022, 01:00 by User Not Found
    Clinical Research News |In recent years, a slew of digital health technologies (DHTs), designed to collect and share data remotely, have emerged to capture more data from clinical trials. And while uptake has been slow, new guidelines and regulations from the United States and European Union are finally creating a practical framework for an operation that promises to shift the dial. But do we finally have the structures we need to build 21st-century clinical trials that hasten access to life-saving treatments? Or is there more we could be doing with data?
    Full story
  • CD Formulation Offers Forced Degradation Studies

    May 26, 2022, 09:33 by
    To ensure the safety and efficacy of the drug product, chemical stability is of paramount importance. Earlier this month, CD Formulation announced its decision to launch forced degradation studies to help researchers find ways to promote drug stability.
    Full story
  • Alfa Chemistry Catalysts Releases Asymmetric Organocatalysts for Chemical Reactions

    May 26, 2022, 09:31 by
    As a reliable source for versatile catalysts, Alfa Chemistry Catalysts today announces that it has launched a rich of collection of asymmetric organocatalysts, including chiral amines, chiral amino acids, chiral ammonium salts, chiral bicyclic guanidines, chiral diols, chiral imidazolidinones, chiral isothioureas, chiral n-heterocyclic carbenes (NHC), chiral oxazaborolidines, chiral sulfonic acids, cinchona alkaloids, and prolines, proline analogs. All can be used to accelerate different types of chemical reactions for research and production, whereas all are of high purity and of high-popularity among consumers.
    Full story
  • CD Genomics Supercharges Transcriptomics Research by Digital RNA Sequencing Technology

    May 26, 2022, 09:31 by
    Full story
  • MicrobioSeq Releases Nanopore-Based Microbial Epigenomics Solutions to Accelerate Your Research

    May 26, 2022, 09:31 by
    Full story
  • Cloud-Based Registry for HIV Clinical Study, Next-Gen Gene and Cell Therapy Research, More

    May 26, 2022, 01:00 by User Not Found
    Clinical Research News | NIAID awards $577 million to establish nine Antiviral Drug Discovery Centers; Allelica and Invitae build clinical artificial intelligence architecture for breast cancer; a new COVID-19 antibody test is used in vital pandemic research; next-generation gene and cell therapy research promote more efficient clinical trials; and more.
    Full story
  • uMotif – the patient-first data capture and decentralized clinical trials platform – announces $25.5m of new investment from a fund managed by Athyrium Capital Management

    May 25, 2022, 13:14 by
    uMotif – the patient-first data capture and decentralized clinical trials platform – announces $25.5m of new investment from a fund managed by Athyrium Capital Management LONDON and NEW YORK, May 25, 2022-- uMotif today announced a new investment of $25.5m from a fund managed by Athyrium Capital Management, LP, the New York-based investment firm. The new funding will support continued scale up of uMotif's unique patient-first software platform for clinical research.
    Full story
  • STEMart Introduces Biocompatibility Evaluation of Breathing Gas Pathways in Medical Devices

    May 25, 2022, 09:12 by
    STEMart expands its Biocompatibility Testing services and introduces biocompatibility evaluation of breathing gas pathways in medical devices.
    Full story
  • Amerigo Scientific Supports Microbiology Research with the Launch of HHD BROTH

    May 25, 2022, 09:12 by
    Amerigo Scientific now introduces HHD Broth to the life science research community.
    Full story
  • Creative Diagnostics Announces Antigens for Epstein-Barr Virus Antibody Tests

    May 25, 2022, 09:12 by
    Creative Diagnostics recently launches recombinant antigens p18 and p23 (viral capsid antigens, VCA), p54 and p138 (early antigens, EA) and EBNA1 (nuclear antigen, EBNA).
    Full story
  • Daman enters collaboration to provide further insights into patients' lives in the effort to deliver better outcomes for people with psoriatic arthritis (PsA)

    May 25, 2022, 09:12 by
    Daman has announced they have signed an agreement with Janssen Pharmaceutica NV (Janssen) to deliver a digital health tool to be used in a clinical study among people living with psoriatic arthritis.
    Full story
  • Follow the Money: Patient-Centric Clinical Trials, Cancer Research Biomarkers, More

    May 25, 2022, 01:00 by User Not Found
    Clinical Research News| Funding for virtual and hybrid clinical trial and execution models, cancer research, pharmaceutical analytics, and more.
    Full story
  • ENPICOM launches versatile display data analysis solution to accelerate antibody selection while maximizing precision

    May 24, 2022, 14:15 by
    ENPICOM has announced the upcoming expansion of the capabilities of the IGX Platform to unlock seamless analysis of antibody panning data.
    Full story
  • Pronalyse Unveils Therapeutic Enzyme Characterization Service for Your Drug Development

    May 24, 2022, 09:27 by
    Full story
  • Creative Proteomics Lipidomics Platform Boosts Short Chain Fatty Acids Research

    May 24, 2022, 09:27 by
    Full story
  • «
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119 (current)
  • 120
  • »